APOBEC3H

APOBEC3H
Identifiers
AliasesAPOBEC3H, A3H, ARP-10, ARP10, apolipoprotein B mRNA editing enzyme catalytic subunit 3H
External IDsHomoloGene: 52306 GeneCards: APOBEC3H
Gene location (Human)
Chr.Chromosome 22 (human)[1]
Band22q13.1Start39,097,224 bp[1]
End39,104,067 bp[1]
Orthologs
SpeciesHumanMouse
Entrez

164668

n/a

Ensembl

ENSG00000100298

n/a

UniProt

Q6NTF7

n/a

RefSeq (mRNA)

NM_001166002
NM_001166003
NM_001166004
NM_181773

n/a

RefSeq (protein)

NP_001159474
NP_001159475
NP_001159476
NP_861438

n/a

Location (UCSC)Chr 22: 39.1 – 39.1 Mbn/a
PubMed search[2]n/a
Wikidata
View/Edit Human

DNA dC->dU-editing enzyme APOBEC-3H, also known as Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3H or APOBEC-related protein 10, is a protein that in humans is encoded by the APOBEC3H gene.[3]

Function

This gene encodes a member of the apolipoprotein B mRNA-editing enzyme catalytic polypeptide (APOBEC) family of proteins. The encoded protein is a cytidine deaminase that has antiretroviral activity by generating lethal hypermutations in viral genomes. Polymorphisms and alternative splicing in this gene influence its antiretroviral activity and are associated with increased resistance to human immunodeficiency virus type 1 infection in certain populations. There are only one to two members of this family of genes in nonprimate mammals but at least seven members in primates. APOBEC3H is an antiviral effector. In Old world monkeys APOBEC3H has efficient antiviral activity against primate lentiviruses and it is sensitive to inactivation by the simian immunodeficiency virus Vif protein, and is capable of hypermutating retroviral genomes. The typical human APOBEC3H gene is inherently poorly expressed in primate cells and is ineffective at inhibiting retroviral replication.[4] Importantly, different people have different strengths and potencies of APOBEC3H. People with version of the gene for APOBEC3H which produce stable variations of the protein can successfully limited HIV-1's ability to replicate.[5]

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000100298 - Ensembl, May 2017
  2. ↑ "Human PubMed Reference:".
  3. ↑ "Entrez Gene: apolipoprotein B mRNA editing enzyme".
  4. ↑ OhAinle M, Kerns JA, Malik HS, Emerman M (2006). "Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H". J. Virol. 80 (8): 3853–62. doi:10.1128/JVI.80.8.3853-3862.2006. PMC 1440450. PMID 16571802.
  5. ↑ Refsland EW, Hultquist JF, Luengas EM, Ikeda T, Shaban NM, Law EK, Brown WL, Reilly C, Emerman M, Harris RS (2014). "Natural Polymorphisms in Human APOBEC3H and HIV-1 Vif Combine in Primary T Lymphocytes to Affect Viral G-to-A Mutation Levels and Infectivity". PLoS Genet. 10 (11): e1004761. doi:10.1371/journal.pgen.1004761. PMC 4238949. PMID 25411794.

Further reading

  • Wedekind JE, Dance GS, Sowden MP, Smith HC (2003). "Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business". Trends Genet. 19 (4): 207–16. doi:10.1016/S0168-9525(03)00054-4. PMID 12683974.
  • OhAinle M, Kerns JA, Malik HS, Emerman M (2006). "Adaptive Evolution and Antiviral Activity of the Conserved Mammalian Cytidine Deaminase APOBEC3H". J. Virol. 80 (8): 3853–62. doi:10.1128/JVI.80.8.3853-3862.2006. PMC 1440450. PMID 16571802.
  • Vartanian JP, Guétard D, Henry M, Wain-Hobson S (2008). "Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions". Science. 320 (5873): 230–3. doi:10.1126/science.1153201. PMID 18403710.
  • Ooms M, Majdak S, Seibert CW, et al. (2010). "The Localization of APOBEC3H Variants in HIV-1 Virions Determines Their Antiviral Activity". J. Virol. 84 (16): 7961–9. doi:10.1128/JVI.00754-10. PMC 2916534. PMID 20519396.
  • Tan L, Sarkis PT, Wang T, et al. (2009). "Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1". FASEB J. 23 (1): 279–87. doi:10.1096/fj.07-088781. PMC 2626612. PMID 18827027.
  • Collins JE, Wright CL, Edwards CA, et al. (2004). "A genome annotation-driven approach to cloning the human ORFeome". Genome Biol. 5 (10): R84. doi:10.1186/gb-2004-5-10-r84. PMC 545604. PMID 15461802.
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2002). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
  • Harari A, Ooms M, Mulder LC, Simon V (2009). "Polymorphisms and Splice Variants Influence the Antiretroviral Activity of Human APOBEC3H". J. Virol. 83 (1): 295–303. doi:10.1128/JVI.01665-08. PMC 2612324. PMID 18945781.
  • Zhen A, Wang T, Zhao K, et al. (2010). "A Single Amino Acid Difference in Human APOBEC3H Variants Determines HIV-1 Vif Sensitivity". J. Virol. 84 (4): 1902–11. doi:10.1128/JVI.01509-09. PMC 2812409. PMID 19939923.
  • OhAinle M, Kerns JA, Li MM, et al. (2008). "Anti-retroelement Activity of APOBEC3H was Lost Twice in Recent Human Evolution". Cell Host Microbe. 4 (3): 249–59. doi:10.1016/j.chom.2008.07.005. PMC 2608726. PMID 18779051.
  • Köck J, Blum HE (2008). "Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H". J. Gen. Virol. 89 (Pt 5): 1184–91. doi:10.1099/vir.0.83507-0. PMID 18420796.
  • Li MM, Wu LI, Emerman M (2010). "The Range of Human APOBEC3H Sensitivity to Lentiviral Vif Proteins". J. Virol. 84 (1): 88–95. doi:10.1128/JVI.01344-09. PMC 2798431. PMID 19828612.
  • Dang Y, Siew LM, Wang X, et al. (2008). "Human Cytidine Deaminase APOBEC3H Restricts HIV-1 Replication". J. Biol. Chem. 283 (17): 11606–14. doi:10.1074/jbc.M707586200. PMC 2430661. PMID 18299330.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.